Drugs.com
JANUARY 18, 2025
SATURDAY, Jan. 18, 2025 -- A slice of tasty, stretchy, creamy cheese may soon be easier to come by for those on a dairy-free diet.Researchers in Canada are working to create plant-based cheeses with all the taste and texture of traditional, dairy.
Covalent Modifiers
JANUARY 18, 2025
Mohammad Anwar Hossain, Abigail K. Mayo, Anirban Ghoshal, Sharon A. Taft-Benz, Elizabeth J. Anderson, Noah L. Morales, Katia D. Pressey, Ava M. Vargason, Kim L. R. Brouwer, Nathaniel J. Moorman, Mark T. Heise, Timothy M. Willson bioRxiv 2025.01.13.632788; doi: [link] RA-0002034 (1) is a potent covalent inhibitor targeting the alphavirus nsP2 cysteine protease.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Chemical Biology and Drug Design
JANUARY 18, 2025
Early metastasis induces dismal prognosis of gallbladder cancer. Morusin reverses epithelial-mesenchymal transition and suppresses metastasis of gallbladder cancer cells by modulating STAT3/HIF-1 signaling. ABSTRACT Gallbladder cancer is the most prevalent malignancy of the biliary tract and has a dismal overall survival even in the present day. The development of new drugs holds promise for improving the prognosis of this lethal disease.
Tecan
JANUARY 18, 2025
By David Keller As a healthcare instrument moves through its lifecycle, its engineering, development and customer support need to progress in parallel. In order to extend a products profitability for as long as possible and to maintain customer loyalty, you must plan for its evolution from the beginning. Involving an OEM partner in your product lifecycle management (LCM) from the start can help you to create products that are easier to service with a lower total cost of ownership (TCO), with few
Speaker: Simran Kaur, Co-founder & CEO at Tattva.Health
AI is transforming clinical trials—accelerating drug discovery, optimizing patient recruitment, and improving data analysis. But its impact goes far beyond research. As AI-driven innovation reshapes the clinical trial process, it’s also influencing broader healthcare trends, from personalized medicine to patient outcomes. Join this new webinar featuring Simran Kaur for an insightful discussion on what all of this means for the future of healthcare!
Expert insights. Personalized for you.
240 
Let's personalize your content